Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma
Clinical trial NCT03617328 · COMPLETED
Trial details
- NCT number
- NCT03617328
- Sponsor
- Craig L Slingluff, Jr
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-13
- Primary completion
- 2024-01-19
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.